About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 510 record(s)
Req # A-2019-002051
All final inspection reports of licensed cannabis micro-processors in Ontario to March 23, 2020.Organization: Health Canada
June 2020
Req # A-2019-001425
Health Canada clinical executive summaries for every submission pertaining to GARDASIL 9, which include: indications for use in men, Indigenous, First-Nation, Indian (registered with the Indian Registry) or Native American people/persons.Organization: Health Canada
June 2020
Req # A-2019-001553
Final version or latest draft and emails associated with Order Paper question Q-2522, put on notice on June 7, 2019. Time frame is June 7, 2019 to September 12, 2019.Organization: Health Canada
June 2020
Req # A-2019-001794
All records on a product presently considered for access by Health Canada's Special Access Program (SAP). The product is KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE INJECTION. From January 01, 2015 to December 31, 2019.Organization: Health Canada
June 2020
Req # A-2019-001860
Copies of all external submissions which went into crafting the 2013 Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Data by Sex.Organization: Health Canada
June 2020
Req # A-2020-000174
Adverse Reaction Report (AER). Report number: E2B_02987919.Organization: Health Canada
June 2020
Req # A-2020-000208
All records describing the isolation of a SARS-COV-2 virus, directly from a sample taken from a diseased patient, where the patient sample was not first combined with any other source of genetic material (i.e. monkey kidney cells aka vero cells;…Organization: Health Canada
June 2020
Req # A-2020-000273
Any Abbreviated New Drug Submission (ANDS) submissions that are still under review that were initially filed between June 1, 2017 and July 15, 2017. How many of these submissions are still under review?Organization: Health Canada
June 2020
Req # A-2020-000274
Any Abbreviated New Drug Submission (ANDS) submissions (i.e., the sponsor, the reference product and the proposed product) that are still under review that were initially filed between June 1, 2017 and July 15, 2017.Organization: Health Canada
June 2020
Req # A-2020-000277
All Health Canada documents produced from November 1, 2019 to May 25, 2020, related to Canada's need for medical personal protective equipment, testing equipment and/or ventilators for intensive care.Organization: Health Canada
June 2020